Share This Page

Alzheimer's And Dementia Weekly

Support & Insight for the Autumn of Life

News

Leqembi: Pioneering Alzheimer’s Drug Faces Challenge in Europe

July 26, 2024 No Comments

While the initial headlines might seem discouraging, there’s always more to the story. 🌟

Weight-loss Drug Ozempic Cuts Dementia Risk 48%

July 21, 2024 No Comments

University of Oxford research revealed groundbreaking findings that could reshape dementia prevention. Ozempic (AKA Semaglutide/Wegovy), a type-2 diabetes and weight-loss drug, seems to significantly reduce the risk of dementia.

How to Choose Between Kisunla vs. Leqembi, The New Alzheimer’s Drugs

July 14, 2024 3 Comments

The newest Alzheimer’s drugs, Kisunla and Leqembi, are the first to actually slow down Alzheimer’s. How do they compare to each other?

Kisunla Approved by FDA, 2nd Drug to Actually Slow Alzheimer’s

July 5, 2024 No Comments

VIDEO + ARTICLE: Kisunla (generic name: Donanemab) slowed cognitive and functional decline 35%. Once-monthly infusions reduced Alzheimer’s plaque 84%.

Unlocking Terazosin’s Potential for Dementia with Lewy Bodies

June 26, 2024 1 Comment

Three FDA-Approved drugs, terazosin, doxazosin, and alfuzosin, have a happy side effect; they boost energy production in brain cells. New studies suggest this slows or prevents Dementia with Lewy Bodies.

Person Encircling the Date on the Calendar

Making it Easier to Take Leqembi for Alzheimer’s

June 23, 2024 1 Comment

A drug for Alzheimer’s, called Leqembi, might soon be given less often. Right now, patients get it through a drip every two weeks. The idea is to change this to once a month.

FDA Endorses Donanemab, Revolutionary Alzheimer’s Treatment

June 11, 2024 No Comments

The unanimous 11-0 FDA vote clears an exciting path for this new Alzheimer’s drug.

LEQEMBI® for Alzheimer’s Now in USA, China, Japan, South Korea

June 4, 2024 1 Comment

South Korea joined other countries in approving LEQEMBI® (generic lecanemab) for mild cognitive impairment, mild and early Alzheimer’s. Learn how Leqembi is treating Alzheimer’s around the world.

Bigger is Better: Brain Size Up 7%, Dementia Down 25%

May 28, 2024 1 Comment

In a span of 40 years, why did average brain size increase and dementia rates drop? A new UC-Davis study explores environmental factors behind this silent revolution.

Seroquel-quetiapine Prescriptions Drop 15% After Dementia Warning

May 22, 2024 3 Comments

“People with dementia living in nursing homes and in the community were prescribed less and we did not detect negative health impacts for these groups.”

Bill Gates discussing Alzheimer's research on CBS Sunday Morning

Bill Gates Discusses Alzheimer’s Research on CBS Sunday Morning

November 9, 2025

In this web exclusive, Microsoft co-founder and philanthropist Bill Gates talks with CBS News chief medical correspondent Dr. Jon LaPook about research into Alzheimer’s, a disease which affected his own father.

Ronald Reagan’s Alzheimer’s Letter: Still Relevant, Still Moving

November 7, 2025

In November 1994, President Reagan hand-wrote this profound message to America, sharing his Alzheimer’s diagnosis. His words broke stigmas and myths. Watch Nancy Reagan describe that moment. Read his magnificent letter.

man, brain, trauma, alzheimer's disease, dementia, forget, disease, alzheimer, elder, concept, memory, lost, disorder, mental, loss, nervous, problem, health, depression, information, trouble, mind, symptom, awareness, brain, dementia, dementia, dementia, dementia, dementia, forget, forget, alzheimer

How Long Do People Live With Dementia?

November 6, 2025

Every dementia journey is unique — but large studies now show clear patterns. Age, type of dementia, and general health all play major roles in how long a person lives after diagnosis.